# A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition

> **NCT02498288** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 36 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Isotretinoin: Reference Medication 1
- **DRUG:** Isotretinoin: Reference Medication 2
- **DRUG:** Isotretinoin: Test Medication

## Key facts

- **NCT ID:** NCT02498288
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-31
- **Primary completion:** 2013-07-15
- **Final completion:** 2013-07-15
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02498288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02498288, "A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02498288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*